Today's guest is Nicole Baker, CEO at biologit. Founded around 2020, biologit - who was a finalist in the Best Application of AI in Healthcare at the 2024 AI Awards - has pioneered an innovative approach to pharmacovigilance, the practice of monitoring the effects of medical drugs after they have been licensed for use.

Topics include:

0:00 Applying AI and NLP to analyze pharmaceutical literature efficiently

3:06 Helping pharma companies and service providers save time

4:10 Building AI with open-access literature to analyze unstructured data

6:18 How Gen AI isn’t fully validated for pharmacovigilance compliance

9:14 Pharma adoption of AI is slow due to learning and change management

11:19 How AI streamlines event detection and global biomedical data monitoring

14:19 Signing 12 new contracts, expanding to top pharma